Your browser doesn't support javascript.
loading
Anthracycline-containing versus carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial.
Gao, Hong-Fei; Wu, Zhiyong; Lin, Ying; Song, Xiang-Yang; Cao, Yin; Chen, Qian-Jun; Zhang, Gangling; Fu, Peifen; Liu, Zhenzhen; Zhang, Liu-Lu; Yang, Ci-Qiu; Yang, Mei; Zhu, Teng; Ji, Fei; Li, Jie-Qing; Cheng, Min-Yi; Wang, Kun.
Afiliación
  • Gao HF; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Wu Z; Diagnosis & Treatment Center of Breast Diseases, Shantou Central Hospital, Shantou, Guangdong, China.
  • Lin Y; Breast Disease Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Song XY; Breast Center, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, China.
  • Cao Y; Breast Central, Dongguan People's Hospital, Dongguan, Guangdong, China.
  • Chen QJ; Breast Central, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China.
  • Zhang G; Breast Surgery, Baotou Cancer Hospital, China.
  • Fu P; Breast Surgery, 1st Affiliated Hospital, School of Medical, Zhejiang University, China.
  • Liu Z; Department of Breast Cancer Center, Affiliated Tumor Hospital of Zhengzhou University: Henan Cancer Hospital, Zhengzhou, Henan, China.
  • Zhang LL; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Yang CQ; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Yang M; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Zhu T; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Ji F; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Li JQ; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Cheng MY; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No.123 Huifu West, Yuexiu District, Guangzhou, Guangdong 510080, China.
Ther Adv Med Oncol ; 13: 17588359211009003, 2021.
Article en En | MEDLINE | ID: mdl-33959195
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: China